ELAN · NYSE · Drug Manufacturers - Specialty & Generic

Elanco Animal Health

Develops medicines, vaccines, and feed products for pets and farm animals.

$24.11
After-hours close−0.02 (−0.06%)
At close$24.13(−1.49%)

Breakdown13F · Form 4

Institutions 116.95%Insiders 1.04%

A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.

Shares outstanding 499.45M · Float 494.82M · 99.1% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
Dodge & Cox67.40M13.49%13FAug 13, 2026
FMR LLC56.95M11.40%13FAug 13, 2026
BlackRock, Inc.48.85M9.78%13FAug 7, 2026
Primecap Management Co/CA/45.45M9.10%13FAug 14, 2026
T. Rowe Price Investment Management, Inc.28.75M5.76%13FAug 14, 2026

Institutions13F, as of Jun 30, 2026

530 holders · 584.13M shares · 81 new positions · 241 increased · 213 reduced · 77 closed

HolderShares% outstandingChg q/qFiled
Dodge & Cox67.40M13.49%−1.55MAug 13, 2026
FMR LLC56.95M11.40%+6.02MAug 13, 2026
BlackRock, Inc.48.85M9.78%+1.23MAug 7, 2026
Primecap Management Co/CA/45.45M9.10%−395.9KAug 14, 2026
T. Rowe Price Investment Management, Inc.28.75M5.76%−5.88MAug 14, 2026
Dimensional Fund Advisors LP25.42M5.09%+890.1KAug 11, 2026
Vanguard Portfolio Management LLC22.67M4.54%+35.0KAug 13, 2026
Vanguard Capital Management LLC22.61M4.53%+271.4KAug 13, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Dodge & Cox13.90%68.94M13GMay 14, 2026
FMR LLC10.50%52.20M13GFeb 5, 2026
Primecap Management Co/CA/9.22%45.84M13GMay 13, 2026
BlackRock, Inc.8.90%44.02M13GOct 17, 2025
T. Rowe Price Investment Management, Inc.6.40%31.55M13GNov 14, 2025
Vanguard Capital Management5.25%26.14M13GApr 29, 2026
Dimensional Fund Advisors LP5.10%25.42M13GJul 14, 2026

InsidersForm 4

InsiderRoleShares% outstandingFiled
Jeffrey N. Simmonsdirector, officer: PRESIDENT, CEO AND DIRECTOR2.22M0.45%May 19, 2026
Ramiro Martin Cabralofficer: SEE REMARKS283.9K0.06%Mar 5, 2026
Ellen de Brabanderofficer: SEE REMARKS280.8K0.06%Apr 7, 2026
R. David Hooverdirector261.5K0.05%May 26, 2026
David S. Kinardofficer: SEE REMARKS214.3K0.04%Mar 5, 2026
Todd S. Youngofficer: SEE REMARKS206.5K0.04%Mar 5, 2025
Lawrence Erik Kurziusdirector188.6K0.04%Aug 21, 2026
Rajeev A. Modiofficer: SEE REMARKS160.8K0.03%May 19, 2026
Timothy J. Bettingtonofficer: SEE REMARKS143.3K0.03%Mar 5, 2026
Robert M. VanHimbergenofficer: EVP and CFO137.5K0.03%Aug 10, 2026

1 ten-percent owner holds 18.45M shares by Form 4, outside the officers-and-directors figure above · 13 people have not refiled in the last 18 months (658.2K shares), so they are not in the figure above

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Aug 20, 2026
Lawrence Erik Kurziusdirector
Purchase40,000$23.40188,647
Aug 18, 2026
Shiv O'Neillofficer: GC AND CORP SEC
Purchase3,998$23.5887,832
Aug 12, 2026
Michael J. Harringtondirector
Purchase5,000$21.82131,451
Aug 7, 2026
Paul Herendeendirector
Purchase10,000$23.69111,687
Aug 7, 2026
Robert M. VanHimbergenofficer: EVP and CFO
Purchase4,200$23.08137,516
May 15, 2026
Jeffrey N. Simmonsdirector, officer: PRESIDENT, CEO AND DIRECTOR
Purchase4,971$20.09171,971
May 15, 2026
Rajeev A. Modiofficer: SEE REMARKS
Purchase4,911$20.35160,812
Dec 12, 2025
Lawrence Erik Kurziusdirector
Purchase10,000$21.30131,773
Dec 11, 2025
Jeffrey N. Simmonsdirector, officer: PRESIDENT, CEO AND DIRECTOR
Purchase22,000$21.75167,000
Dec 11, 2025
Robert M. VanHimbergenofficer: EVP and CFO
Purchase6,950$21.64124,233

CongressHouse and Senate disclosures

Not reported.